Navigation Links
Israeli Start-up That Treats Knee Cartilage Injuries Raises $15M for U.S. Pivotal Clinical Trial
Date:2/10/2016

PRINCETON, New Jersey and OR AKIVA, Israel, February 10, 2016 /PRNewswire/ --

Regentis Biomaterials Ltd., a leader in the field of cartilage repair, announces the closing of its Series D investment round on February 5, 2016. The $15 million investment was led by Haisco Pharmaceutical Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and was joined by existing Regentis investors including Medica Partners, SCP Vitalife Partners, Generali Financial Holdings and both the Technion Research & Development Foundation and the Technion Innovation Opportunities Fund.

Regentis Biomaterials has developed GelrinC®, a proprietary hydrogel based on technology invented at The Technion - Israel Institute of Technology. Implanted as a liquid, GelrinC is cured in-situ to form a resorbable implant which is gradually replaced by newly regenerated cartilage. As part of the investment, Haisco will serve as the exclusive distributor of GelrinC in China.

The investment will be used primarily for conducting a pivotal clinical trial on GelrinC in the United States as required to obtain marketing approval from the FDA, according to Alastair Clemow, Ph.D., Regentis Biomaterial's CEO.  In the earlier trial in Europe and Israel, GelrinC provided patients suffering from cartilage injuries with exceptional relief from knee pain and improved function to return to normal activities. The key features of the product- suitability for a wide range of injuries, ease of use and excellent mid-term results - provide the surgeon with an exciting new technique for treating patients. "We look forward to collaborating with Haisco to expand the potential of this technology in the Chinese market over the coming years," stated Clemow.

"We are delighted to enter the Israeli market with a significant investment in Regentis Biomaterial," said Haisco's CEO, Wang Junmin. "We see great potential for GelrinC in China and look forward to applying our know-how and experience in bringing this exciting surgical technology to the China market for the benefit of patients, surgeons and hospitals alike."

About Regentis Biomaterials 

Regentis Biomaterials is a privately held company developing biodegradable hydrogels for the regeneration of damaged or diseased tissue. The company's first product is GelrinC©, a cell-free implant for the treatment of injuries to articular knee cartilage.

For more information, please visit http://www.regentis.co.il.

About Haisco Pharmaceutical Group Co., Ltd. 

Haisco Pharmaceutical Group, founded in 2000, is a publicly listed company focusing on marketing and sales of internally-developed therapeutic drugs. Haisco ranks third in size in China's chemical pharmaceutical industry. The company's products are sold to more than 3,000 hospitals throughout China with annual sales of over US$800 million.

For media inquiries, please contact:
Livnat Ben-Zur
Phone: +972-4-6265502
Livnat@Regentis.co.il


'/>"/>
SOURCE Regentis Biomaterials Ltd.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court
2. Israeli Medical Device Company FlowSense Acquired by Baxter
3. Boston MedTech Advisors Enters Into 50th Engagement with Israeli Life Sciences Companies
4. Alaska Structures Delivers $3.5 Million Dollar Mobile Field Hospital to Israeli Defense Forces to Increase Medical Preparedness
5. CareFusion To Invest $100 Million In Israeli Infusion Pump Maker
6. Untold News, an American Non-Profit, Awards $10,000 (U.S.) Each to Israeli Inventors of a Cancer Bullet, a Metal Ligament Prosthesis, and a Bendable Plastic Touch Screen Display In First Annual Ceremony
7. RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage
8. RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments
9. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
10. New Cloud-Based Investigator Portal from Veeva Systems Speeds Clinical Study Start-Up
11. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... SAN FRANCISCO (PRWEB) , ... July 19, 2019 ... ... Blumenthal Nordrehaug Bhowmik De Blouw LLP, lodged a putative class action lawsuit ... California with the legally required thirty minute uninterrupted meal periods and rest periods. ...
(Date:7/18/2019)... WEST GROVE, Pa. (PRWEB) , ... July 18, 2019 , ... ... with the Bushel and Berry Collection of homegrown edible berry bushes. , ... bring beauty and healthy, delicious fruit to any garden or on the patio in ...
(Date:7/17/2019)... ... , ... Princeton, New Jersey – Supply Chain Wizard , a leader ... a 2019 ‘Cool Vendor’ by Gartner, Inc. in Supply Chain Execution Technologies. , According ... on two things. First, given the clear preferences of supply chain users, we looked ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... July 17, 2019 , ... Guruji Mahendra Trivedi, founder ... on today’s issues affecting humanity at practical and spiritual levels. Guruji Mahendra Trivedi ... July 20, 2019. , Guruji Mahendra Trivedi offers these powerful workshops to deepen ...
(Date:7/17/2019)... ... ... It took just several small incisions by St. Luke's University Health ... nerves under Amber Walck’s scalp, and suddenly her two-year agony with migraines was history. ... headaches began without warning. About 39 million Americans suffer from migraines that range ...
(Date:7/17/2019)... ... July 17, 2019 , ... A new study led by ... the American Medical Association (JAMA), shows for the first time that New York’s ... state. Sepsis is the body’s extreme response to infection. It kills more than 275,000 ...
(Date:7/13/2019)... ... 14, 2019 , ... Dr. Rupa Jolly, dentist and wife of Dr. Tarun ... of Most Influential New Orleanians in 2019. She joins more than 20 other locals ... made an impact on the New Orleans community. , Combining their backgrounds in science ...
(Date:7/13/2019)... ... July 12, 2019 , ... China Focus ... Center , sponsored by Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health ... The conference attracted Fosun Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, ...
Breaking Medicine News(10 mins):